Experiment 324811

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

SERRATIGEN

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismSerratia marcescens (ENTEROBACTERIACEAE)
CitationIKEKAWA,T: IKEDA,Y: FUKUOKA,F:. (1975). ANTITUMOR ACTIVITY OF POLYSACCHARIDES FROM SERRATIA MARCESCENS.. 66()
Amount utilized
Compound isolated
Dose amount150.0 MG
Number2
Percent yield38%
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE
Expression resultTWD